Insilicos Using $1.2M SBIR Grant for 400-Subject Study Investigating Cardiovascular Biomarkers

Building on the results of a 38-patient study published in July, the company hopes to develop its PreClue cardiovascular disease biomarker panel as a clinical diagnostic for either screening or treatment-planning purposes.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.